Founded in Cambridge, Massachusetts, Cambridge Nutraceuticals (CamNutra) is dedicated to combating chronic health conditions through clinically-proven natural healthcare products. Their core mission is to protect individuals against diseases like cardiovascular disease using proprietary formulations. The company's flagship product, Ateronon, is designed to safeguard cardiovascular health and has undergone extensive development and clinical testing by research teams from Cambridge and Harvard Universities.
Notable affiliations include collaborations with leading research institutions such as Cambridge University and Harvard University. CamNutra has invested over £12 million in the development of Ateronon, underscoring their commitment to scientific rigor and efficacy. The company has made a significant impact by providing evidence-based health supplements that contribute to longer, healthier lives.